- Home
- THRY vs SVRA Comparison
THRY vs SVRA Comparison
Compare THRY & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRY
- SVRA
- Stock Information
- Founded
- THRY 2012
- SVRA 2007
- Country
- THRY United States
- SVRA United States
- Employees
- THRY N/A
- SVRA N/A
- Industry
- THRY Industrial Machinery/Components
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- THRY Industrials
- SVRA Health Care
- Exchange
- THRY Nasdaq
- SVRA Nasdaq
- Market Cap
- THRY 594.8M
- SVRA 528.3M
- IPO Year
- THRY 2020
- SVRA N/A
- Fundamental
- Price
- THRY $11.94
- SVRA $2.17
- Analyst Decision
- THRY Strong Buy
- SVRA Buy
- Analyst Count
- THRY 5
- SVRA 7
- Target Price
- THRY $21.40
- SVRA $7.57
- AVG Volume (30 Days)
- THRY 326.3K
- SVRA 1.3M
- Earning Date
- THRY 07-31-2025
- SVRA 08-11-2025
- Dividend Yield
- THRY N/A
- SVRA N/A
- EPS Growth
- THRY N/A
- SVRA N/A
- EPS
- THRY N/A
- SVRA N/A
- Revenue
- THRY $771,903,000.00
- SVRA N/A
- Revenue This Year
- THRY N/A
- SVRA N/A
- Revenue Next Year
- THRY N/A
- SVRA N/A
- P/E Ratio
- THRY N/A
- SVRA N/A
- Revenue Growth
- THRY N/A
- SVRA N/A
- 52 Week Low
- THRY $10.03
- SVRA $1.89
- 52 Week High
- THRY $20.92
- SVRA $5.11
- Technical
- Relative Strength Index (RSI)
- THRY 32.91
- SVRA 41.53
- Support Level
- THRY $12.10
- SVRA $2.00
- Resistance Level
- THRY $12.66
- SVRA $2.30
- Average True Range (ATR)
- THRY 0.43
- SVRA 0.15
- MACD
- THRY -0.15
- SVRA 0.02
- Stochastic Oscillator
- THRY 6.52
- SVRA 33.33
About THRY Thryv Holdings Inc.
Thryv Holdings Inc is dedicated to supporting local, independent service-based businesses and emerging franchises by providing a cloud-based software platform, and marketing solutions to entrepreneurs. Its company is built upon a rich legacy in the marketing and advertising industry. The group are provider of SaaS all-in-one small business management software in addition to providing print and digital marketing solutions to SMBs. Its solutions enable SMB clients to attract and generate new business leads, manage their customer relationships efficiently with artificial intelligence (AI) tools and automation, and run their day-to-day operations to save time, compete and win in today's SMB environment. The group has two business segments; Thryv SaaS and Thryv Marketing Services.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.